Biocure Technology Inc logo

CURE - Biocure Technology Inc Share Price

C$0.2 -0.0  -16.7%

Last Trade - 26/02/21

Sector
Energy
Size
Micro Cap
Market Cap £451k
Enterprise Value £311k
Revenue £n/a
Position in Universe th / 2684
Bullish
Bearish
Unlock CURE Revenue
Momentum
Relative Strength (%)
1m -11.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -39.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 30th Sep 2004 2005 2006 2007 2008 2009 2010E 2011E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 December 2009, GravisEnergy Corp revenues was not reported. Net loss totaledC$5K vs. income of C$0K. Net loss reflects Office andGeneral increase from C$1K to C$6K (expense), InterestIncome decrease of 41% to C$1K (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CURE Revenue Unlock CURE Revenue

Net Income

CURE Net Income Unlock CURE Revenue

Normalised EPS

CURE Normalised EPS Unlock CURE Revenue

PE Ratio Range

CURE PE Ratio Range Unlock CURE Revenue

Dividend Yield Range

CURE Dividend Yield Range Unlock CURE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CURE EPS Forecasts Unlock CURE Revenue
Profile Summary

Biocure Technology Inc, formerly Gravis Energy Corp, is a Canada based company that is engaged in the Bio Pharmaceutical sector. The Company operates through BiocurePharm, a South Korean-based Bio Pharmaceutical company specializing in the development and potential commercialization of biosimilar pharmaceutical products. BiocurePharm is in the process of clinical trials of five biosimilar products in South Korea, including Interferon Beta 1b, Filgrastim and Ranibizumab. Interferon Beta 1b is used for treating relapsing forms of multiple sclerosis (MS); Filgrastim is used to treat neutropenia, a lack of certain white blood cells caused by bone marrow transplants, chemotherapy, and other conditions; Ranibizumab is used for treating macular degeneration. BiocurePharm is also developing a foot and mouth disease vaccine, a hair growth production product and a breast cancer detection kit.

Directors
Last Annual September 30th, 2009
Last Interim December 31st, 2009
Incorporated August 24, 2007
Public Since March 27, 2008
No. of Shareholders: n/a
No. of Employees: n/a
Sector Energy
Industry Uranium
Index
Exchange Canadian Securities Exchange
Shares in Issue 4,000,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CURE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CURE
Upcoming Events for CURE
Frequently Asked Questions for Biocure Technology Inc
What is the Biocure Technology Inc share price?

As of 26/02/21, shares in Biocure Technology Inc are trading at C$0.2, giving the company a market capitalisation of £451k. This share price information is delayed by 15 minutes.

How has the Biocure Technology Inc share price performed this year?

Shares in Biocure Technology Inc are currently trading at C$0.2 and the price has moved by -37.5% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biocure Technology Inc price has moved by -44.22% over the past year.

What are the analyst and broker recommendations for Biocure Technology Inc?

There are no analysts currently covering Biocure Technology Inc.

When will Biocure Technology Inc next release its financial results?

Biocure Technology Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2010-12-31
What is the Biocure Technology Inc dividend yield?

Biocure Technology Inc does not currently pay a dividend.

Does Biocure Technology Inc pay a dividend?

Biocure Technology Inc does not currently pay a dividend.

When does Biocure Technology Inc next pay dividends?

Biocure Technology Inc does not currently pay a dividend.

How do I buy Biocure Technology Inc shares?

To buy shares in Biocure Technology Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biocure Technology Inc?

Shares in Biocure Technology Inc are currently trading at C$0.2, giving the company a market capitalisation of £451k.

Where are Biocure Technology Inc shares listed? Where are Biocure Technology Inc shares listed?

Here are the trading details for Biocure Technology Inc:

Country of listing: Canada
Exchange: CNX
Ticker Symbol: CURE
What kind of share is Biocure Technology Inc?

We were not able to load our ranking data for Biocure Technology Inc

Is there a Biocure Technology Inc share price forecast 2021?

We were not able to load any forecast data for Biocure Technology Inc.

How can I tell whether the Biocure Technology Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biocure Technology Inc. Over the past six months, the relative strength of its shares against the market has been 0.69%. At the current price of C$0.2, shares in Biocure Technology Inc are trading at -13.4% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biocure Technology Inc PE Ratio?

We were not able to find PE ratio data for Biocure Technology Inc.

Who are the key directors of Biocure Technology Inc?

We were unable to find the directors for Biocure Technology Inc.

Who are the major shareholders of Biocure Technology Inc?

Here are the top five shareholders of Biocure Technology Inc based on the size of their shareholding:

Lee (Sang Mok) Individual Investor
Percentage owned: 27.34% (27.3m shares)
Kim (Sang Goo) Individual Investor
Percentage owned: 0.2% (197k shares)
Lichtenwald (Konstantin) Individual Investor
Percentage owned: 0.05% (47.1k shares)
Similar to CURE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.